Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check18 days agoChange DetectedNew history entry added for version 14 (Study Status) on 2026-07-31, with an additional date entry on 2026-08-24. An older entry dated 2026-01-08 was removed from the history.SummaryDifference0.4%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry 'Revision: v3.6.5' was added to the study record history, and the previous 'Revision: v3.6.4' entry was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.6.4 was added to the record history. The previous revision v3.6.3 was removed, updating the page's version history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.6.3 was added to the study's history, and the previous revision v3.6.2 was removed from the current revision list.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page history now shows a newer site revision label (v3.6.2) replacing the previous revision (v3.6.0), indicating a minor internal update to the page.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.